U.S. FDA Reaffirms Commitment to COVID-19 Vaccine Transparency

In COVID-19, Latest News by Precision Vaccinations

While Emergency Use Authorizations (EUA) have received increased attention during the COVID-19 public health emergency, they are not a new tool to the US Food and Drug Administration (FDA). 
The Commissioner of FDA Stephen M. Hahn M.D., took a moment on November 17, 2020, to reaffirm FDA’s commitment to transparency around the EUA process and share some updates on our plan to provide more information about FDA’s decisions to issue, revise or revoke EUAs for vaccines.

Read More